2022 Research Grants
Gabrielle’s Angel Foundation’s Medical Advisory Board recently selected 6 talented early career scientists to receive Medical Research Awards for a total of $1.35M in grants! Awards are...
Your support of Gabrielle’s Angel Foundation allows us to push the boundaries of what is scientifically possible for those living with blood cancer. Meet the dedicated research scientists whose cutting-edge ideas are giving patients reason to hope and hear all about their latest breakthroughs below!
Researchers Identify Key Source of T Cell “Exhaustion”
New research from Gabrielle’s Angels grantees Cigall Kadoch and Iannis Aifantis shows the commanding role of BAF complexes in mediating T cell exhaustion. Targeting these complexes could reduce...
Gabrielle’s Angel Foundation welcomes new Medical Advisory Board member Dr. Eirini Papaetrou
We are delighted to welcome Dr. Eirini Papaetrou to the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research! Dr. Papapetrou is a Professor of Oncological Sciences,...
Study reveals epigenetic vulnerability of acute myeloid leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that causes uncontrolled accumulation of white blood cells. Because of the poor outcomes of this disease, researchers across the globe have...
Study reveals how chronic blood cancer transitions to aggressive disease
A study from Washington University School of Medicine in St. Louis suggests a strategy for preventing a chronic, slow-growing type of blood cancer from progressing to an aggressive form of...
NIH initiative to systematically investigate and establish function of every human gene
The National Institutes of Health is launching a program to better understand the function of every human gene and generate a catalog of the molecular and cellular consequences of inactivating each...
New Grantees Announced
In June, Gabrielle’s Angel Foundation’s Medical Advisory Board selected 16 talented early career scientists to receive funding for a total of $1.8M in grants! Awards ranged from $25,000...
Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs
Congratulations to Gabrielle’s Angels grantees Dr. Ann Mullally and Dr. Shannon Elf for their recent publication in September’s issue of Blood. Read the full paper here:...
Preventing ‘chemo brain’ with antioxidants targeting spinal fluid
Up to three quarters of patients receiving cancer chemotherapy suffer from “chemo brain” — a long-term side effect that makes it harder to remember things, maintain attention, and learn new...
A better roadmap for beating a deadly leukemia
Acute myeloid leukemia, or AML, is the most common acute blood cancer in adults — and one of the most difficult to treat. Scientists at Oregon Health & Science University have discovered a...
11th Annual Medical Research Symposium
On May 24th, 2022 we hosted our 11th annual Medical Research Symposium at Feinstein’s/54 Below in New York City. We hosted researchers both past and present…some we funded as far back...
Scientists uncover a new approach for treating aggressive cancer
Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during...